Concord Drugs Limited (CONCORD.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹64.03 (-1.60%) as of
Key statistics
- Market cap
- 843.60M
- P/E (TTM)
- 38.34
- EPS (TTM)
- 1.67
- Dividend yield
- 0.00%
- 52-week range
- 63.00 – 92.52
- Beta
- 0.59
- Revenue (TTM)
- 860.69M
- Profit margin
- 2.38%
- Volume
- 5.48k
About Concord Drugs Limited
Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products; ready-to-fill pellets and multiple unit pellets system; other drugs in the form of tablets, capsules, injectables such as small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers. Concord Drugs Limited was incorporated in 1995 and is based in Hyderabad, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Hyderabad, India
- Employees
- 250
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- RUNGTA IRRIGATION LTD. (RUNGTAIR.BO)
- CADSYS (INDIA) LIMITED (CADSYS-SM.NS)
- DCM SHRIRAM INTERNATIONAL LIMI (DCMSIL.BO)
- Swati Projects Limited (SWATIPRO.BO)
- INCON ENGINEERS LTD. (INCON.BO)
- DCM FINANCIAL SERVICES LTD. (DCMFINSERV.BO)
- MANGALAM GLOBAL ENTERPRISE LIM (MGEL.BO)
- SMITHS & FOUNDERS (INDIA) LIMI (SMFIL.BO)